<DOC>
	<DOCNO>NCT01809444</DOCNO>
	<brief_summary>The aim study compare efficacy safety prednisone versus sub-antimicrobial dose doxycycline ( 50 mg/d ) treatment active moderate-severe Graves ' Orbitopathy ( GO ) .</brief_summary>
	<brief_title>Prednisone Versus Doxycycline Treatment Graves ' Orbitopathy</brief_title>
	<detailed_description>Graves ' orbitopathy autoimmune disease characterize inflammatory phase follow fibrosis . Surgery correct eyelid swelling , proptosis , diplopia effective , do inflammatory phase pass . To arrest inflammatory phase , several type immunosuppressive treatment investigate . Corticosteroids first-choice immunosuppressive treatment , successful outcome 50-70 % patient . However , long time usage corticosteroid often cause severe side-effects . Sub-antimicrobial dose doxycycline posse know anti-inflammatory effect separate antibacterial mode action . This mode action lead routine use sub-antimicrobial dose doxycycline treat inflammatory autoimmune disease , rosacea , periodontitis multiple sclerosis . The mechanism inhibit lymphocyte proliferation production colony-stimulating factor , inflammatory cytokine , immunoglobulin , factor think play role orbital autoimmune process . These mechanism make , theory , attractive option doxycycline treat Graves ' Orbitopathy . In addition , adverse event report doxycycline administer 3 month patient periodontitis rosacea . We propose compare effect safety sub-antimicrobial dose doxycycline versus prednisone treat non-sight threatening , moderate-severe , inflammatory GO .</detailed_description>
	<mesh_term>Graves Ophthalmopathy</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>Confirmed diagnosis Graves ' Orbitopathy ( define Bartley Gorman ) Eyelid retraction ( upper eyelid margin superior corneoscleral limbus primary gaze without frontalis muscle contraction ) association one following : Thyroid dysfunction abnormal regulation ( increase serum thyroxine triiodothyronine level , decrease serum thyroid stimulate hormone level , absence thyroid radioiodine uptake suppression administration triiodothyronine , presence thyroid stimulate immunoglobulin serum ) Exophthalmos Extraocular muscle involvement ( restrictive myopathy objective evidence enlarge muscle ) Optic nerve dysfunction ( abnormal visual acuity , color vision , pupillary reaction perimetry attributable cause ) OR Thyroid dysfunction abnormal regulation association one following : Exophthalmos Extraocular muscle involvement Optic nerve dysfunction Moderatesevere GO According EUGOGO statement , patient moderatesevere GO usually one following：lid retraction≥2mm , moderate severe soft tissue involvement , exophthalmos≥3mm normal race gender , inconstant , constant diplopia . Clinical activity score ≥ 3 Being euthyroid least 1 month date inclusion Must able swallow tablet Written inform consent obtain Mild Graves ' Orbitopathy Sightthreatening Graves ' Orbitopathy Clinical activity score ＜ 3 Previous treatment GO Oral steroid , intravenous steroid , radiotherapy Pregnant female determine positive ( serum urine ) human chorionic gonadotrophin ( hCG ) test screen prior dosing , lactate female Uncontrolled diabetes hypertension History mental / psychiatric disorder Hepatic dysfunction ( Albumin ( Alb ) , Aspartate Aminotransferase ( AST ) , Alanine Aminotransferase ( ALT ) Alkaline phosphates level must within normal range eligibility ) Renal impairment ( Urea Creatinine level must within normal range ) Doxycycline Prednisone allergy intolerance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>